Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

876 Results

Drug

treosulfan

Other Name(s): Trecondyv®

Quick Link(s):

Jan 2025

Oncologie moléculaire et médecine personnalisée

Drug

tucatinib

Other Name(s): Tukysa™

Quick Link(s):

Drug Monograph, Patient Info Sheet

Feb 2025

Regimen

TARL; TARL(RAMP)

Cancer Type:

Lung,

Small Cell

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

tarlatamab (Compassionate)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Feb 2025

Document

Ontario-Cervical-Screening-Program-Recommendations-for-Cervical-Screening-and-Colposcopy-with-HPV-testing.pdf

New

Feb 2025

Document

Ontario-Cervical-Screening-Program-Transition-Guidance-for-ages-21-24.pdf

New

Feb 2025

Document

Ontario-Cervical-Screening-Program-Guidance-for-Vaginal-Vault-Testing.pdf

New

Feb 2025

Ontario Cervical Screening Program

Toolkit for Ontario Colposcopists

Test de la voûte vaginale

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Updated

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

Updated

Mar 2025

Pages